MEX3A and ovarian cancer: The effect of 9 upregulated RBPs on clinical prognosis was evaluated by Kaplan–Meier Plotter (http://kmplot.com/), and only MEX3A was found to be associated with worse overall survival (OS) and progression-free survival (PFS) of ovarian cancer (Fig. 1B).